Home > Medical Engineering

Medical Engineering

 

Materials innovations designed to stimulate tissue regeneration recognised by industry award

A highly competitive award, sponsored by Amgen International, recognises BioCeramic Therapeutics' use of materials innovations to benefit patients with some of the most serious orthopaedic and dental conditions by stimulating and assisting in the body's natural tissue regeneration processes. The materials innovations also have potential future applications in soft tissue regeneration.

15 January 2010: BioCeramic Therapeutics

 

Funding round in BioCeramic Therapeutics headed by Imperial Innovations

Leading technology commercialisation and investment company Imperial Innovations (AIM: IVO, 'Imperial Innovations'), together with Longbow Capital LLP, has led a funding round for BioCeramic Therapeutics, with a first closing of £1.12 million.

10 January 2010: BioCeramic Therapeutics

 

New chairman succeeds Sir Richard Sykes at BioCeramic Therapeutics

Dr Stephan Rietiker has been appointed chairman of the board of directors of the emerging leader in the field of novel biomaterials for healthcare, BioCeramic Therapeutics (BCT).

19 October 2009: BioCeramic Therapeutics

 

Elderly patients have a high risk of stroke within six months of a heart attack

Twenty percent of older patients who have suffered a heart attack have a one in 25 chance of being hospitalized for a stroke within six months of discharge from the hospital, according to research at Yale.

14 April 2006: Yale University

 

More patients would refuse treatment if they knew the outcome would mean greatly impaired quality of life

More patients would refuse life-sustaining treatment if they knew the outcome would be a life of severe functional or cognitive impairment, according to a study by a Yale researcher published Thursday in the New England Journal of Medicine.

13 April 2006: Yale University

 

Anti-fungal agent that curbed cocaine use in rodents has opposite effect in humans

Ketoconazole, an anti-fungal agent that helps curb cocaine use in laboratory rats, stimulates rather than reduces cocaine and heroin use in humans, according to a study by researchers at Yale School of Medicine.

11 April 2006: Yale University

 

Yale researchers report on brain activity believed related to sudden infant death syndrome

Neurons thought to play a key role in sudden infant death syndrome are located near some of the largest arteries in the brain, according to a study by a Yale School of Medicine research team published in this week's issue of the journal Nature Neuroscience.

08 April 2006: Yale University

 

Biodegradable polymers in medical applications

Rapra Technology, Europe's leading polymer research and test house, has secured 1.4 Million Euros of EU funding and assembled a consortium that will develop highly innovative supercritical fluid processing technology in order to make advanced multifunctional biodegradable polymer devices.

27 March 2006: Rapra Technology Limited

 

Going the extra mile for specialized heart attack care

Diverting ambulances with patients suffering a heart to a hospital providing emergency angioplasty rather than a closer hospital with no ability to provide this specialized care, may be feasible for the majority of Americans, researchers at Yale School of Medicine and the University of Michigan report in Circulation.

13 March 2006: Yale University

 

Researchers identify gene that protects against kidney stones

New Haven, Conn, Yale School of Medicine researchers report in Nature Genetics this week that they have identified a gene whose function protects the body against kidney stones.

13 March 2006: Yale University

 

Whiplash injury much more severe when head is turned

Persons whose heads are turned at the time of a rear impact collision risk a much more serious whiplash injury with potentially chronic symptoms, and a current Yale School of Medicine study explains why.

13 March 2006: Yale University

 

ADHD medication might also treat hyperactivity symptoms in autism

Methylphenidate, a medication used to treat attention-deficit hyperactivity disorder, may be effective in treating hyperactivity symptoms in children with autism and related pervasive developmental disorders, researchers report in the November Archives of General Psychiatry.

22 November 2005: Yale University

 

Study has implications for vaccine design and autoimmune diseases

A report in Nature November 17 by Yale School of Medicine researchers emphasizes which cells are important in mounting an antibody response to invading microbes.

18 November 2005: Yale University

 

Sleep apnea significantly increases risk for stroke and death

Sleep apnea, a condition where people stop breathing repeatedly while asleep, increases the risk of stroke and death, according to a study from Yale School of Medicine published November 10 in the New England Journal of Medicine.

10 November 2005: Yale University

 

Panel at Yale will examine issues of women and health care

The Women Faculty Forum at Yale and the Yale Office of WorkLife will present a free and public forum on November 16 focusing on women's healthcare from a variety of perspectives.

02 November 2005: Yale University

 

Study clarifies source of lymph node swelling in infections

Contrary to popular belief, lymph nodes swell due to recruitment of lymphocytes that are not specific for any given microbe, according to a report by Yale School of Medicine researchers in this week's Proceedings of the National Academy of Sciences.

25 October 2005: Yale University

 

Cool therapy reduces brain injury and death from oxygen loss in newborns

Infants born with oxygen loss who are given an innovative therapy that lowers their entire body temperature by four degrees within the first six hours of life, have a better chance of survival and lower incidence of brain injury, according to a report in today's issue of The New England Journal of Medicine.

13 October 2005: Yale University

 

Streamlining treatment of heart attack patients

In the first study of its kind, researchers at Yale School of Medicine show how hospitals can streamline procedures to reduce the time they take to treat heart attack patients.

29 September 2005: Yale University

 

Overlapping genetic factors in pathological gambling and major depression

The correlation between pathological gambling and major depression in middle-aged men appears to be heavily influenced by overlapping genetic factors, according to a study by researchers at Yale School of Medicine and Washington University's School of Medicine.

22 September 2005: Yale University

 

Yale procedure cuts recurrence of aggressive uterine cancer

A state-of-the-art treatment program developed at Yale School of Medicine increases survival from the aggressive uterine papillary serous carcinoma and spares some patients the need for additional therapy.

22 September 2005: Yale University

 

Gene that controls the severity of asthma identified

School of Medicine researchers identified a gene prevalent in the population that controls the clinical severity of asthma, according to their report in this week's Proceedings of the National Academy of Sciences.

20 September 2005: Yale University

 

Promising diagnostic tools for multiple sclerosis

Yale School of Medicine researchers, in collaboration with the University of Connecticut Health Center, have identified three rapid diagnostic methods that can target antibodies commonly found in multiple sclerosis patients, greatly improving potential diagnosis and treatment.

20 September 2005: Yale University

 

Aortic aneurysm associated with decreased incidence of atherosclerosis

Oddly enough, having an aneurysm in the ascending aorta is significantly associated with decreased incidence of atherosclerosis, according to a study by Yale School of Medicine researchers published this month in Chest.

19 September 2005: Yale University

 

Eating and body weight regulated by specific neurons

Researchers at Yale School of Medicine provide direct evidence that two parts of a neuronal system, one that promotes eating and another that suppresses eating, are critical for the acute regulation of eating and body weight, according to a study published online in the September 11 issue of Nature Neuroscience.

12 September 2005: Yale University

 

Most embryos produced during IVF do not result in live births

Researchers at Yale School of Medicine have found that 85 percent of embryos transferred during in vitro fertilization fail to become live births, highlighting the need for improving diagnostic techniques to identify viable embryos.

08 September 2005: Yale University

 
 
1 2 3 4 5 6 7 8
 

 

 

© 2010 NewMaterials.com